These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7948633)

  • 1. A ceramic system for continuous release of acetylsalicylic acid.
    Moldovan KM; Bajpai PK
    Biomed Sci Instrum; 1994; 30():175-80. PubMed ID: 7948633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a ceramic matrix system for continuous delivery of azidothymidine.
    Nagy EA; Bajpai PK
    Biomed Sci Instrum; 1994; 30():181-6. PubMed ID: 7948634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics.
    Cannon MR; Bajpai PK
    Biomed Sci Instrum; 1995; 31():159-64. PubMed ID: 7654955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricalcium phosphate amino acid capsules as a drug delivery system for steroid hormones.
    Benghuzzi HA; England BG; Bajpai PK
    Biomed Sci Instrum; 1991; 27():197-203. PubMed ID: 2065155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term sustained delivery of 3'-azido-2',3'-dideoxythymidine in vivo by means of HA and TCP delivery devices.
    Benghuzzi H
    Biomed Sci Instrum; 2000; 36():343-8. PubMed ID: 10834256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro release of azidothymidine (AZT) by ceramic drug delivery systems.
    Benghuzzi HA; Barbaro RM; Bajpai PK
    Biomed Sci Instrum; 1990; 26():151-6. PubMed ID: 2334759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo delivery of estradiol from ceramic drug delivery devices.
    Benghuzzi HA; England BG; Bajpai PK
    Biomed Sci Instrum; 1991; 27():181-7. PubMed ID: 2065153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of hydrophilic compounds by resorbable and biodegradable ceramic drug delivery devices.
    Benghuzzi HA; England BG; Bajpai PK
    Biomed Sci Instrum; 1992; 28():179-82. PubMed ID: 1322731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization.
    Daculsi G; LeGeros RZ; Nery E; Lynch K; Kerebel B
    J Biomed Mater Res; 1989 Aug; 23(8):883-94. PubMed ID: 2777831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained delivery of aspirin by means of ALCAP ceramics.
    Snow KR; Muzina DJ; Bajpai PK
    Biomed Sci Instrum; 1989; 25():203-11. PubMed ID: 2742967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of TiO2 and Ag2O addition on tricalcium phosphate ceramics.
    Seeley Z; Bandyopadhyay A; Bose S
    J Biomed Mater Res A; 2007 Jul; 82(1):113-21. PubMed ID: 17269142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition.
    Kamitakahara M; Ohtsuki C; Miyazaki T
    J Biomater Appl; 2008 Nov; 23(3):197-212. PubMed ID: 18996965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution rate of zinc-containing beta-tricalcium phosphate ceramics.
    Ito A; Senda K; Sogo Y; Oyane A; Yamazaki A; Legeros RZ
    Biomed Mater; 2006 Sep; 1(3):134-9. PubMed ID: 18458394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physiological response associated with large particles of TCP, HA, and ALCAP implants using raw 264.7 cells.
    Thorns M; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 2001; 37():287-92. PubMed ID: 11347404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic release by tricalcic phosphate bone implantation. In vitro and in vivo pharmacokinetics of different galenic forms].
    Thomazeau H; Langlais F
    Chirurgie; 1997 Jan; 121(9-10):663-6. PubMed ID: 9138328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin.
    Mileti IF; Bajpai PK
    Biomed Sci Instrum; 1995; 31():177-82. PubMed ID: 7654958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory response and degradation of three types of calcium phosphate ceramic in a non-osseous environment.
    van der Meulen J; Koerten HK
    J Biomed Mater Res; 1994 Dec; 28(12):1455-63. PubMed ID: 7876285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameters of protein delivery using hydroxyapatite in simulated body fluid.
    Tscholl B; Billotte WG; Reed D; Smith S; Kreinbrink K; Bajpai PK
    Biomed Sci Instrum; 1997; 34():70-5. PubMed ID: 9603015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bioactive glass ceramics on the expression of bone-related genes and proteins in vitro.
    Knabe C; Stiller M; Berger G; Reif D; Gildenhaar R; Howlett CR; Zreiqat H
    Clin Oral Implants Res; 2005 Feb; 16(1):119-27. PubMed ID: 15642039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HA, TCP and ALCAP bioceramic capsules on the viability of human monocyte and monocyte derived macrophages.
    Ross L; Benghuzzi H; Tucci M; Callender M; Cason Z; Spence L
    Biomed Sci Instrum; 1996; 32():71-9. PubMed ID: 8672693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.